Credit Suisse’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-77,918
| Closed | -$2.18M | – | 4600 |
|
|
2022
Q1 | $2.18M | Sell |
77,918
-96,615
| -55% | -$2.65M | ﹤0.01% | 2016 |
|
|
2021
Q4 | $4.77M | Buy |
174,533
+64,495
| +59% | +$1.75M | ﹤0.01% | 2064 |
|
|
2021
Q3 | $2.99M | Buy |
110,038
+87,669
| +392% | +$2.17M | ﹤0.01% | 2497 |
|
|
2021
Q2 | $382K | Buy |
22,369
+2,025
| +10% | +$37.9K | ﹤0.01% | 3998 |
|
|
2021
Q1 | $425K | Sell |
20,344
-14,219
| -41% | -$328K | ﹤0.01% | 3865 |
|
|
2020
Q4 | $791K | Buy |
34,563
+748
| +2% | +$14.2K | ﹤0.01% | 3504 |
|
|
2020
Q3 | $551K | Sell |
33,815
-44,130
| -57% | -$799K | ﹤0.01% | 3335 |
|
|
2020
Q2 | $1.05M | Buy |
77,945
+60,301
| +342% | +$702K | ﹤0.01% | 2864 |
|
|
2020
Q1 | $209K | Sell |
17,644
-248,607
| -93% | -$5.51M | ﹤0.01% | 3625 |
|
|
2019
Q4 | $6.63M | Buy |
266,251
+200,519
| +305% | +$4.06M | ﹤0.01% | 1685 |
|
|
2019
Q3 | $1.12M | Buy |
65,732
+38,067
| +138% | +$693K | ﹤0.01% | 2935 |
|
|
2019
Q2 | $629K | Sell |
27,665
-1,302
| -4% | -$35.1K | ﹤0.01% | 3266 |
|
|
2019
Q1 | $933K | Buy |
28,967
+284
| +1% | +$8.79K | ﹤0.01% | 2947 |
|
|
2018
Q4 | $808K | Buy |
28,683
+13,745
| +92% | +$403K | ﹤0.01% | 2948 |
|
|
2018
Q3 | $429K | Sell |
14,938
-19,567
| -57% | -$588K | ﹤0.01% | 3384 |
|
|
2018
Q2 | $1.29M | Buy |
34,505
+10,579
| +44% | +$415K | ﹤0.01% | 2813 |
|
|
2018
Q1 | $941K | Buy |
23,926
+437
| +2% | +$16K | ﹤0.01% | 2998 |
|
|
2017
Q4 | $761K | Sell |
23,489
-4,652
| -17% | -$140K | ﹤0.01% | 3187 |
|
|
2017
Q3 | $878K | Buy |
28,141
+14,172
| +101% | +$419K | ﹤0.01% | 3191 |
|
|
2017
Q2 | $391K | Buy |
+13,969
| New | +$316K | ﹤0.01% | 3312 |
|
|
2017
Q1 | – | Sell |
-14,297
| Closed | -$173K | – | 4162 |
|
|
2016
Q4 | $173K | Sell |
14,297
-934
| -6% | -$12.1K | ﹤0.01% | 3850 |
|
|
2016
Q3 | $241K | Sell |
15,231
-10,406
| -41% | -$157K | ﹤0.01% | 3744 |
|
|
2016
Q2 | $332K | Buy |
+25,637
| New | +$401K | ﹤0.01% | 3654 |
|
|
2016
Q1 | – | Sell |
-39,173
| Closed | -$881K | – | 4380 |
|
|
2015
Q4 | $881K | Sell |
39,173
-23,260
| -37% | -$460K | ﹤0.01% | 2919 |
|
|
2015
Q3 | $1.46M | Buy |
62,433
+47,741
| +325% | +$1.32M | ﹤0.01% | 2499 |
|
|
2015
Q2 | $421K | Buy |
+14,692
| New | +$385K | ﹤0.01% | 3830 |
|
Credit Suisse's XENT Position: Q2 2022 in Review
Credit Suisse sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 77,918 shares — an estimated $2.18M sold.
Credit Suisse first reported a position in XENT in Q2 2015 and held it in 26 quarters. The position peaked at $6.63M in Q4 2019. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Credit Suisse reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Credit Suisse sold 77,918 Intersect ENT, Inc shares in Q2 2022, an estimated $2.18M.
- Credit Suisse first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 26 quarters.
- Credit Suisse's Intersect ENT, Inc position peaked at $6.63M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Credit Suisse's 13F filing for Q2 2022, filed 12 Aug 2022.